Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 7-14 , April 2007

Aristolochic Acid Nephropathy: The Hong Kong Perspective

  • Wing-Tat Poon
    • ,
  • Chi-Kong Lai
    • ,
  • Albert Yan-Wo Chan

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint requests to: Dr. Albert Y.W. Chan, Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong SAR, China. Fax: (+852) 2370-0969

References 

  1. Peters G , Hedwall PR . Aristolochic acid intoxication: a new type of impairment of urinary concentrating ability . Arch Int Pharmacodyn Ther . 1963;145:334–355
  2. Wu SH . Two cases of acute renal failure caused by Mutong . Jiang Xi Zhong Yi . 1964;10:12–14 [In Chinese]
  3. Hong YS , Huang YL , Wang YJ . Over-dose of Mutong causes renal failure and death . Zhe Jiang Zhong Yi Za Zhi . 1965;8:32; [In Chinese]
  4. Zhou FJ , Lu HW , Nie CF . Toxicity of Mutong causes acute renal failure . Zhonghua Shenzanbing Za Zhi . 1988;4:223–224 [In Chinese]
  5. Ma H , Cheung P . Literature review of MuTong related adverse events . In: Guanmutong Shenduxing Yanjiu . Beijing: Chemical Industry Press; 2005;p. 1–64 [In Chinese]
  6. Tsui L . Review of the widespread toxicity caused by Aristolochiae Fangchi and Manshuriensis . Chinese Traditional and Herbal Drugs . 2001;32:88–89 [In Chinese]
  7. van Ypersele de Strihou C , Vanherweghem JL . The tragic paradigm of Chinese herbs nephropathy . Nephrol Dial Transplant . 1995;10:157–160
  8. Vanherweghem JL , Depierreux M , Tielemans C , Abramowicz D , Dratwa M , Jadoul M , et al.   Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs . Lancet . 1993;341:387–391
  9. Nortier JL , Martinez MCM , Schmeiser HH , Arlt VM , Bieler CA , Petein M , et al.   Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) . N Engl J Med . 2000;342:1686–1692
  10. But PP . Need for correct identification of herbs in herbal poisoning . Lancet . 1993;341:637
  11. Vanhaelen M , Vanhaelen-Fastre R , But P , Vanherweghem JL . Identification of aristolochic acid in Chinese herbs . Lancet . 1994;343:174
  12. Schmeiser HH , Bieler CA , Wiessler M , van Ypersele de Strihou C , Cosyns JP . Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy . Cancer Res . 1996;56:2025–2028
  13. Mengs U , Lang W , Poch JA . The carcinogenic action of aristolochic acid in rats . Arch Toxicol . 1982;51:107–119
  14. Bieler CA , Stiborova M , Wiessler M , Cosyns JP , van Ypersele de Strihou C , Schmeiser HH . 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy . Carcinogenesis . 1997;18:1063–1067
  15. Cosyns JP , Dehoux JP , Guiot Y , Goebbels RM , Robert A , Bernard AM , et al.   Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? . Kidney Int . 2001;59:2164–2173
  16. Chen HY , Ma BY , Grant A , Lampert N . Time to abandon the term “Chinese herbs nephropathy” . Kidney Int . 2001;60:2039–2040
  17. Pourrat J , Montastruc JL , Lacombe JL , Cisterne JM , Rascol O , Dumazer P . Nephropathy associated with Chinese herbal drugs. 2 cases . Presse Med . 1994;23:1669; [In French]
  18. Pena JM , Borras M , Ramos J , Montoliu J . Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion . Nephrol Dial Transplant . 1996;11:1359–1360
  19. Lord GM , Tagore R , Cook T , Gower P , Pusey CD . Nephropathy caused by Chinese herbs in the UK . Lancet . 1999;354:481–482
  20. Meyer MM , Chen TP , Bennett WM . Chinese herb nephropathy . BUMC Proc . 2000;13:334–337
  21. Schwetz BA . From the Food and Drug Administration . JAMA . 2001;285:2705
  22. Kessler DA . Cancer and herbs . N Engl J Med . 2000;342:1742–1743
  23. Kumar V , Poonam  , Prasad AK , Parmar VS . Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities . Nat Prod Rep . 2003;20:565–583
  24. The State Pharmacopoeia Commission of P.R. China  . In: Pharmacopoeia of the People's Republic of China . Vol. 1: Beijing: Chemical Industry Press; 2000;
  25. Chan W , Hui KM , Poon WT , Lee KC , Cai Z . Differentiation of herbs linked to “Chinese herb nephropathy” from the liquid chromatographic determination of aristolochic acids . Anal Chim Acta . 2006;576:112–116
  26. Jong TT , Lee MR , Hsiao SS , Hsai JL , Wu TS , Chiang ST , et al.   Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry . J Pharm Biomed Anal . 2003;33:831–837
  27. Mengs U . Acute toxicity of aristolochic acid in rodents . Arch Toxicol . 1987;59:328–331
  28. Mengs U , Stotzem CD . Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology . Arch Toxicol . 1993;67:307–311
  29. Arlt VM , Schmeiser HH , Pfeifer GP . Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR . Carcinogenesis . 2001;22:133–140
  30. Robisch G , Schimmer O , Goggelmann W . Aristolochic acid is a direct mutagen in Salmonella typhimurium . Mutat Res . 1982;105:201–204
  31. Zhang H , Cifone MA , Murli H , Erexson GL , Mecchi MS , Lawlor TE . Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid . Food Chem Toxicol . 2004;42:2021–2028
  32. Mengs U . Tumour induction in mice following exposure to aristolochic acid . Arch Toxicol . 1988;61:504–505
  33. Lord GM , Cook T , Arlt VM , Schmeiser HH , Williams G , Pusey CD . Urothelial malignant disease and Chinese herbal nephropathy . Lancet . 2001;358:1515–1516
  34. Balachandran P , Wei F , Lin RC , Khan IA , Pasco DS . Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells . Kidney Int . 2005;67:1797–1805
  35. Depierreux M , Van Damme B , Vanden Houte K , Vanherweghem JL . Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs . Am J Kidney Dis . 1994;24:172–180
  36. Wojcikowski K , Johnson DW , Gobe G . Medicinal herbal extracts—renal friend or foe? Part one: the toxicities of medicinal herbs . Nephrology (Carlton) . 2004;9:313–318
  37. Hong YT , Fu LS , Chung LH , Hung SC , Huang YT , Chi CS . Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs . Pediatr Nephrol . 2006;21:577–579
  38. Nortier JL , Schmeiser HH , Muniz Martinez MC , Arlt VM , Vervaet C , Garbar CH , et al.   Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure . Nephrol Dial Transplant . 2003;18:426–428
  39. Cosyns JP , Jadoul M , Squifflet JP , Wese FX , van Ypersele de Strihou C . Urothelial lesions in Chinese-herb nephropathy . Am J Kidney Dis . 1999;33:1011–1017
  40. Martinez MC , Nortier J , Vereerstraeten P , Vanherweghem JL . Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose . Nephrol Dial Transplant . 2002;17:408–412
  41. Li H , Liu Z , Chen H , Zhu M , Li L . Ultrastructural changes of human proximal tubular epithelial cells incubated with aristolochic acid I . Shenzanbing Yu Toxi Shenyizhi Za Zhi . 2001;10:242–246 [In Chinese]
  42. Lebeau C , Debelle FD , Arlt VM , Pozdzik A , De Prez EG , Phillips DH , et al.   Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies . Nephrol Dial Transplant . 2005;20:2321–2332
  43. Hsin YH , Cheng CH , Tzen JT , Wu MJ , Shu KH , Chen HC . Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells . Apoptosis . 2006;11:2167–2177
  44. Li X , Wang H . Aristolochic acid nephropathy: what we know and what we have to do . Nephrology (Carlton) . 2004;9:109–111
  45. Sun D , Feng J , Dai C , Sun L , Jin T , Ma J , et al.   Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy . Am J Nephrol . 2006;26:363–371
  46. In:  Gold LS ,  Zeiger E editor. Handbook of Carcinogenic Potency and Genotoxicity Databases . Boca Raton, FL: CRC Press; 1997;
  47. Arlt VM , Wiessler M , Schmeiser HH . Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene . Carcinogenesis . 2000;21:235–242
  48. Stiborova M , Frei E , Breuer A , Wiessler M , Schmeiser HH . Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase — (32)P-postlabeling analysis of DNA adduct formation . Mutat Res . 2001;493:149–160
  49. Arlt VM , Stiborova M , Schmeiser HH . Aristolochic acid as a probable human cancer hazard in herbal remedies: a review . Mutagenesis . 2002;17:265–277
  50. Pfau W , Schmeiser HH , Wiessler M . Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA . Carcinogenesis . 1990;11:313–319
  51. Feldmeyer N , Schmeiser HH , Muehlbauer KR , Belharazem D , Knyazev Y , Nedelko T , et al.   Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences . Mutat Res . 2006;608:163–168
  52. Broschard TH , Wiessler M , von der Lieth CW , Schmeiser HH . Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid . Carcinogenesis . 1994;15:2331–2340
  53. Lord GM , Hollstein M , Arlt VM , Roufosse C , Pusey CD , Cook T , et al.   DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy . Am J Kidney Dis . 2004;43:e11–e17
  54. Vanherweghem LJ . Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) . J Altern Complement Med . 1998;4:9–13
  55. De Broe ME . On a nephrotoxic and carcinogenic slimming regimen . Am J Kidney Dis . 1999;33:1171–1173
  56. Kanaan N , Cosyns JP , Jadoul M , Goffin E . The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency . Nephrol Dial Transplant . 2003;18:440–442
  57. Olsen S . Histopathology of drug and toxin induced kidney lesions . Zentralbl Allg Pathol . 1986;132:365–383
  58. Reginster F , Jadoul M , van Ypersele de Strihou C . Chinese herbs nephropathy presentation, natural history and fate after transplantation . Nephrol Dial Transplant . 1997;12:81–86
  59. Yang CS , Lin CH , Chang SH , Hsu HC . Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs . Am J Kidney Dis . 2000;35:313–318
  60. Vanherweghem JL , Abramowicz D , Tielemans C , Depierreux M . Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy . Am J Kidney Dis . 1996;27:209–215
  61. Zhu S , Liu J , Chen L , Li Y , Yao J , Jin C , et al.   Chemopreventive effect of five drugs on renal interstitial fibrosis induced by an aristolochic acid-containing Chinese herb in rats . Am J Nephrol . 2005;25:23–29
  62. Tanaka A , Nishida R , Maeda K , Sugawara A , Kuwahara T . Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? . Clin Nephrol . 2000;53:301–306
  63. Yang SS , Chu P , Lin YF , Chen A , Lin SH . Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis . Am J Kidney Dis . 2002;39:E14
  64. Tanaka A , Nishida R , Yoshida T , Koshikawa M , Goto M , Kuwahara T . Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium? . Intern Med . 2001;40:296–300
  65. Yu Y , Zheng FL , Li H . Chinese herbs-induced renal failure with Fanconi syndrome: a report of 6 cases . Zhonghua Nei Ke Za Zhi . 2003;42:110–112 [In Chinese]
  66. Lee S , Lee T , Lee B , Choi H , Yang M , Ihm CG , et al.   Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid . Nephrology . 2004;9:126–129
  67. Krumme B , Endmeir R , Vanhaelen M , Walb D . Reversible Fanconi syndrome after ingestion of a Chinese herbal ‘remedy’ containing aristolochic acid . Nephrol Dial Transplant . 2001;16:400–402
  68. Izumotani T , Ishimura E , Tsumura K , Goto K , Nishizawa Y , Morii H . An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs . Nephron . 1993;65:137–140
  69. Tanaka A , Nishida R , Yokoi H , Kuwahara T . The characteristic pattern of aminoaciduria in patients with aristolochic acid-induced Fanconi syndrome: could iminoaciduria be the hallmark of this syndrome? . Clin Nephrol . 2000;54:198–202
  70. Tsai CS , Chen YC , Chen HH , Cheng CJ , Lin SH . An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome . Am J Med Sci . 2005;330:153–155
  71. Gillerot G , Jadoul M , Arlt VM , van Ypersele De Strihou C , Schmeiser HH , But PP , et al.   Aristolochic acid nephropathy in a Chinese patient: time to abandon the term “Chinese herbs nephropathy”? . Am J Kidney Dis . 2001;38:E26
  72. Li X , Yang L , Yu Y . An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy . Zhonghua Nei Ke Za Zhi . 2001;40:681–687 [In Chinese]
  73. Chen W , Chen Y , Li A . The clinical and pathological manifestations of aristolochic acid nephropathy—the report of 58 cases . Zhonghua Yi Xue Za Zhi . 2001;81:1101–1105 [In Chinese]
  74. Ng ML, Deng JF. The debate about use of aristolochic acid-containing herb drugs. In: Workshop on Herbal Medicine Poisonings. Taiwan, 2003.
  75. Laing C , Hamour S , Sheaff M , Miller R , Woolfson R . Chinese herbal uropathy and nephropathy . Lancet . 2006;368:338
  76. Lo SHK , Mo KL , Wong KS , Poon SP , Chan CK , Lai CK , et al.   Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis . Nephrol Dial Transplant . 2004;19:1913–1915
  77. Lo SH , Wong KS , Arlt VM , Phillips DH , Lai CK , Poon WT , et al.   Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy . Am J Kidney Dis . 2005;45:407–410
  78. Arlt VM , Alunni-Perret V , Quatrehomme G , Ohayon P , Albano L , Gaid H , et al.   Aristolochic acid (AA)-DNA adduct as markerof AA exposure and risk factor for AA nephropathy-associated cancer . Int J Cancer . 2004;111:977–980
  79. Ma H , Cheung P . The safety of aristolochic herbs . In: Guanmutong Shenduxing Yanjiu . Beijing: Chemical Industry Press; 2005;p. 279–360 [In Chinese]
  80. Hong Kong Department of Health  . Updated Control Measures for Medicinal Herbs Announced . Hong Kong: Hong Kong Department of Health; 2004;
  81. Jong TT , Lee MR , Hsiao SS , Hsai JL , Wu TS , Chiang ST , et al.   Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry . J Pharm Biomed Anal . 2003;33:831–837
  82. Li K . Analysis of aristolochic acid A in root of Herba Asari by Rp– HPLC . LiaoNing Zhong Yi Za Zhi . 2005;32:1080–1081 [In Chinese]
  83. Yang HY , Lin JL , Chen KH , Yu CC , Hsu PY , Lin CL . Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin . J Nephrol . 2006;19:111–114
  84. Cheung TP , Xue C , Leung K , Chan K , Li CG . Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products—a consequence of inappropriate nomenclature and imprecise labelling? . Clin Toxicol (Phila) . 2006;44:371–378
  85. Gold LS , Slone TH . Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert . N Engl J Med . 2003;349:1576–1577
  86. Schaneberg BT , Khan IA . Analysis of products suspected of containing Aristolochia or Asarum species . J Ethnopharmacol . 2004;94:245–249
  87. Ioset JR , Raoelison GE , Hostettmann K . Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens . Food Chem Toxicol . 2003;41:29–36
  88. Ye ZB , Xu J , Mei XB . Influence of long-term use of low dose caulis Aristolochiae manshuriensis on partial nephrectomized rats . Zhongguo Zhong Xi Yi Jie He Za Zhi . 2002;22:447–449 [In Chinese]
  89. Cheng CL , Chen KJ , Shih PH , Lu LY , Hung CF , Lin WC , et al.   Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents . Cancer Lett . 2006;232:236–242
  90. Chan TY , Tam HP , Lai CK , Chan AY . A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines . Ther Drug Monit . 2005;27:53–57
  91. Ma HM , Zhang BL . Comparison among families of Mutong . Zhongguo Zhong Yao Za Zhi . 2002;27:412–418 [In Chinese]
  92. Wu KM , Farrelly JG , Upton R , Chen J . Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development . Phytomedicine . 2006;
  93. Zhu YP . Toxicity of the Chinese herb mu tong (Aristolochia manshuriensis). What history tells us . Adverse Drug React Toxicol Rev . 2002;21:171–177

PII: S1561-5413(07)60003-9

doi: 10.1016/S1561-5413(07)60003-9

Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 7-14 , April 2007

Article Tools